Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair... see more

TSXV:RP - Post Discussion

Replicel Life Sciences Inc > We Asked For It
View:
Post by Ingiboy on Oct 27, 2021 12:11pm

We Asked For It

We asked for an update and we got it.  It wasn't the update we were hoping for but at least we know where we are at.

The market is not impressed obviously:

Recent Trades - All 0 today
Time ET Ex Price Change Volume Buyer Seller Markers
11:51:01 U 0.27 -0.03 3,000 1 Anonymous 124 Questrade K
11:51:01 X 0.275 -0.025 500 1 Anonymous 124 Questrade K
11:51:01 U 0.275 -0.025 500 1 Anonymous 124 Questrade K
               
               
               
               
               
               
               
 

 

 

Comment by BellEnd on Oct 27, 2021 12:17pm
This post has been removed in accordance with Community Policy
Comment by RPINVESTOR1 on Oct 27, 2021 3:12pm
......Lee Buckler behind the wheel of the runaway truck called Replicel..... This news also delays the start of the phase 2 trials in China because he is insisting on the dermal injector being used in the trials. This is crazy! The only good news here is that Shiseido could make a low offer for the Company, avoid arbitration and have a reasonable chance of acquiring Replicel. ........Death by a ...more  
Comment by Ingiboy on Oct 27, 2021 3:35pm
Have we heard these nebulous time estimates before "pushed back our anticipated timeline for marketing application submission by several weeks..." "The company looks forward to revealing the precommercial device to the market and submitting its marketing application submission to regulators in the weeks to come." This is the old "lipstick on a pig".  I was ...more  
Comment by lv_426 on Oct 30, 2021 8:38pm
So glad I got out when I did. Jump into T.GLXY between $2-3. Made my money back plus some. And shed my frustrations with Replicel and Lee. Life is good
Comment by MetzGER on Oct 31, 2021 5:53am
@Lv_426: I am happy to hear about your success. Do You Can recommend other Stocks to invest now?
Comment by lv_426 on Nov 01, 2021 5:34pm
Can't help with any stock picks. I'm into crypto now. Looking for XRP to move higher within the next few months. Definitly the wild west. DYOR for sure
Comment by MetzGER on Dec 14, 2021 4:03am
What is your entry-level course in XRP? And what do you think XRP could Go to?
Comment by Ingiboy on Oct 31, 2021 11:39am
Good move Lv_426 !  I miss your cryptic posts.  It has been a painful ride this past year. Will we ever see this company fulfill it's never ending promises ?  This is my last 12 months regardless.  I am hanging around until they market the Dermal Injector.  I am hoping it is within this next 12 months. The only other thing that may happen is the company is sold which ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities